Figure 1.
PDT treatment of cancer. The PS drug is administered to a patient and via the bloodstream, it is transported to the tumour site, whereby it localises in tumour cells. Laser light is then applied to this site, whereby it penetrates the skin and activates the PS. The PS then undergoes a photoreaction to produce ROS and/or singlet oxygen, which in turn induces cytotoxic cell death in tumour tissues.